BDX : Summary for Becton, Dickinson and Company - Yahoo Finance

U.S. Markets closed

Becton, Dickinson and Company (BDX)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
185.29-0.76 (-0.41%)
At close: 4:02PM EDT
People also watch
BCRBAXAPDADPCB
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close186.05
Open185.99
Bid0.00 x
Ask0.00 x
Day's Range184.25 - 186.14
52 Week Range157.60 - 186.40
Volume577,681
Avg. Volume832,622
Market Cap39.43B
Beta0.98
PE Ratio (TTM)30.84
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield2.92 (1.59%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire24 minutes ago

    Act Now - Shareholder Alert: Monteverde & Associates PC Announces An Investigation Of C.R. Bard, Inc. - BCR

    NEW YORK, April 23, 2017 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a boutique securities class action firm headquartered at the Empire State Building ...

  • The Wall Street Journal43 minutes ago

    Becton Dickinson to Acquire C.R. Bard for $24 Billion

    Becton, Dickinson and Co. said on Sunday that it would acquire C. R. Bard Inc. for $24 billion in the latest merger of medical-supplies manufacturers.

  • Reuters49 minutes ago

    Becton Dickinson to acquire Bard for $24 billion

    U.S. medical equipment supplier Becton Dickinson and Co will acquire C R Bard Inc, in a $24 billion cash-and-stock deal, adding Bard's devices to its portfolio in the high-growth sectors of oncology and surgery, both companies said on Sunday. The deal comes two years after Becton Dickinson acquired CareFusion Corp for $12 billion. It is the latest in a string of deals in the medical technology sector, as manufacturers turn to acquisitions to boost profit margins.